CSSi LifeSciences introduces SmartStudy Design and Feasibility
CSSi LifeSciences, a Glen Burnie, Md.-based provider of fully integrated solutions that span the lifecycle of a new drug or device, has launched its newest product offering in its portfolio of services—SmartStudy Design and Feasibility. CSSi LifeSciences is a partner company of global patient recruitment solutions provider CSSi.
CSSi LifeSciences recognizes patient-centricity in clinical trials needs to be at the forefront of clinical development, and some of the biggest challenges in delivering a successful clinical study are identifying, measuring and understanding its real-world patient population and the implications for the study's design and product marketing claims.
Emerging biopharma companies often have deep scientific in-house expertise but limited clinical trial design experience for regulatory approval. CSSi LifeSciences has developed models that reduce time to market and decrease development costs, incorporating protocol optimization and feasibility, study planning and design, and patient recruitment and site selection in SmartStudy.